ACTIVE SUBSTANCE / INN

RIZATRIPTAN BENZOATE

Brand name(s): RIZATRIPTAN BENZOATE, MAXALT, MAXALT-MLT, RIZAFILM, SYMBRAVO
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA204722
NDA020864
ACTIVE SUBSTANCE
Rizatriptan Benzoate
REGULATORS
FDA
SPONSORS / MAH
ORGANON LLC, PANACEA, GENSCO
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RIZATRIPTAN BENZOATEANDA202244APOTEX INCDiscontinued
RIZATRIPTAN BENZOATEANDA204722PANACEAPrescription
MAXALTNDA020864ORGANON LLCPrescription
MAXALTNDA020864ORGANON LLCDiscontinued
SYMBRAVONDA215431AXSOMEPrescription
RIZAFILMNDA205394GENSCOPrescription
RIZAFILMNDA205394GENSCODiscontinued
MAXALT-MLTNDA020865ORGANONPrescription
MAXALT-MLTNDA020865ORGANONDiscontinued

FULL INTELLIGENCE ON RIZATRIPTAN BENZOATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →